Drug intelligence / Profile preview

EP-3533

Development stage
Unknown
Lead developer
CollMED Laboratories
Modality
Peptides, Small Molecules
Administration
Intravenous
01

Overview

EP-3533 is a gadolinium-free, manganese-based MRI contrast agent specifically designed for the non-invasive detection and quantification of tissue fibrosis. Developed by Collagen Medical, the agent consists of a manganese(II) chelate conjugated to a peptide that exhibits high affinity for Type I collagen, a hallmark protein of fibrotic expansion in the extracellular matrix. By selectively accumulating in collagen-rich areas, EP-3533 enables high-resolution visualization of fibrotic progression in organs such as the liver, heart, and lungs. This targeted approach offers a potential alternative to invasive biopsies and addresses safety concerns associated with gadolinium-based contrast agents, particularly for patients with renal impairment who are at risk for nephrogenic systemic fibrosis.

Other names
Manganese-based collagen-binding contrast agent
02

Targets

COL1 (Collagen type I)

Beyond the preview

Go deeper on EP-3533.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EP-3533.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call